Literature DB >> 9413106

Affinity-purified dengue-2 virus envelope glycoprotein induces neutralizing antibodies and protective immunity in mice.

I Staropoli1, M P Frenkiel, F Mégret, V Deubel.   

Abstract

We constructed a recombinant baculovirus which produces a dengue (DEN)-2 virus envelope (E) protein containing a six-histidine (H6) tag in place of the last 100 amino acids at its C-terminus. The recombinant protein was purified from the supernatant of baculovirus-infected Spodoptera frugiperda insect cell cultures to apparent homogeneity by cation-chelation chromatography (TALON) in which the H6-tagged E-protein was eluted under non-denaturing conditions with 100 mM imidazole at pH 8.0. Mice vaccinated with the purified E mixed with aluminium hydroxide adjuvant showed an immune response of IgM and IgG1, IgG2a and IgG2b isotypes, and neutralizing antibodies, similar to that following immunization with purified inactivated DEN-2 virus. Moreover, mice that received the purified recombinant protein were significantly protected against 200 50% lethal dose of DEN-2 virus. This combination of affinity purified H6-tagged protein and adsorption onto a cationic carrier seems promising for the production of immunogenic particulate proteins, especially DEN protein for the four serotypes, and the development of a new generation of vaccines.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9413106     DOI: 10.1016/s0264-410x(97)00128-x

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

1.  Use of recombinant E protein domain III-based enzyme-linked immunosorbent assays for differentiation of tick-borne encephalitis serocomplex flaviviruses from mosquito-borne flaviviruses.

Authors:  Michael R Holbrook; Robert E Shope; Alan D T Barrett
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

2.  Replication-defective adenoviral vaccine vector for the induction of immune responses to dengue virus type 2.

Authors:  Smita Jaiswal; Navin Khanna; S Swaminathan
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

3.  Humoral and cellular immune response to RNA immunization with flavivirus replicons derived from tick-borne encephalitis virus.

Authors:  Judith H Aberle; Stephan W Aberle; Regina M Kofler; Christian W Mandl
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

4.  Antibody responses to Asian and American genotypes of dengue 2 virus in immunized mice.

Authors:  Lidice Bernardo; Adriana Yndart; Susana Vázquez; Luis Morier; María G Guzmán
Journal:  Clin Diagn Lab Immunol       Date:  2005-02

5.  Immunoglobulin M enzyme-linked immunosorbent assay using recombinant polypeptides for diagnosis of dengue.

Authors:  Elsa Videa; Maria Josefina Coloma; Flavia Barreto Dos Santos; Angel Balmaseda; Eva Harris
Journal:  Clin Diagn Lab Immunol       Date:  2005-07

Review 6.  A molecular evaluation of dengue virus pathogenesis and its latest vaccine strategies.

Authors:  Muhammad Faheem; Ummar Raheel; Muhammad Nasir Riaz; Naghmana Kanwal; Farakh Javed; Najam us Sahar Sadaf Zaidi; Ishtiaq Qadri
Journal:  Mol Biol Rep       Date:  2010-11-24       Impact factor: 2.316

7.  Evaluation of extracellular subviral particles of dengue virus type 2 and Japanese encephalitis virus produced by Spodoptera frugiperda cells for use as vaccine and diagnostic antigens.

Authors:  Miwa Kuwahara; Eiji Konishi
Journal:  Clin Vaccine Immunol       Date:  2010-07-28

8.  Induction of neutralization antibodies in mice by Dengue-2 envelope DNA vaccines.

Authors:  Mariel E Pérez-Vélez; Teresita García-Nieves; Candimar Colón-Sánchez; Idalí Martínez
Journal:  P R Health Sci J       Date:  2009-09       Impact factor: 0.705

9.  Development of a recombinant tetravalent dengue virus vaccine: immunogenicity and efficacy studies in mice and monkeys.

Authors:  David E Clements; Beth-Ann G Coller; Michael M Lieberman; Steven Ogata; Gordon Wang; Kent E Harada; J Robert Putnak; John M Ivy; Michael McDonell; Gary S Bignami; Iain D Peters; Julia Leung; Carolyn Weeks-Levy; Eileen T Nakano; Tom Humphreys
Journal:  Vaccine       Date:  2010-01-22       Impact factor: 3.641

10.  Vaccination with dengue virus-like particles induces humoral and cellular immune responses in mice.

Authors:  Shuo Zhang; Mifang Liang; Wen Gu; Chuan Li; Fang Miao; Xiaofang Wang; Cong Jin; Li Zhang; Fushun Zhang; Quanfu Zhang; Lifang Jiang; Mengfeng Li; Dexin Li
Journal:  Virol J       Date:  2011-06-30       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.